Peregrine Again Escapes Investor Suit Over Lung Cancer Drug
A California federal judge dismissed a consolidated class action against Peregrine Pharmaceuticals Inc. for the second time on Friday, saying the suit had failed to adequately allege that the drugmaker acted...To view the full article, register now.
Already a subscriber? Click here to view full article